Evidence map›Paper›PMID 32257050›Full record

ArticleComputational and structural biotechnology journal2020

PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer.

Lin Li, Qiushi Feng, Xiaosheng Wang

Open access · goldAbstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lin LiBiomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Qiushi FengBiomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Xiaosheng WangBiomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
China Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microsatellite instability (MSI) is a genomic property of the cancers with defective DNA mismatch repair and is a useful marker for cancer diagnosis and treatment in diverse cancer types. In particular, MSI has been associated with the active immune checkpoint blockade therapy response in cancer. Most of computational methods for predicting MSI are based on DNA sequencing data and a few are based on mRNA expression data. Using the RNA-Seq pan-cancer datasets for three cancer cohorts (colon, gastric, and endometrial cancers) from The Cancer Genome Atlas (TCGA) program, we developed an algorithm (PreMSIm) for predicting MSI from the expression profiling of a 15-gene panel in cancer. We demonstrated that PreMSIm had high prediction performance in predicting MSI in most cases using both RNA-Seq and microarray gene expression datasets. Moreover, PreMSIm displayed superior or comparable performance versus other DNA or mRNA-based methods. We conclude that PreMSIm has the potential to provide an alternative approach for identifying MSI in cancer.

Indexed as

ACC, adrenocortical carcinomaAlgorithmAUC, area under the curveBLCA, bladder urothelial carcinomaBRCA, breast invasive carcinomaCancerCESC, cervical squamous cell carcinoma and endocervical adenocarcinomaCHOL, cholangiocarcinomaClassificationCOAD, colon adenocarcinomaCV, cross validationDLBC, lymphoid neoplasm diffuse large B-cell lymphomaESCA, esophageal carcinomaGBM, glioblastoma multiformeGene expression profilingGEO, Gene Expression OmnibusGO, gene ontologyHNSC, head and neck squamous cell carcinomaKICH, kidney chromophobeKIRC, kidney renal clear cell carcinomaKIRP, kidney renal papillary cell carcinomak-NN, k-nearest neighborLAML, acute myeloid leukemiaLGG, brain lower grade gliomaLIHC, liver hepatocellular carcinomaLUAD, lung adenocarcinomaLUSC, lung squamous cell carcinomaMachine learningMESO, mesotheliomaMicrosatellite instabilityMSI, microsatellite instabilityMSS, microsatellite stabilityOV, ovarian serous cystadenocarcinomaPAAD, pancreatic adenocarcinomaPCPG, pheochromocytoma and paragangliomaPPI, protein-protein interactionPRAD, prostate adenocarcinomaREAD, rectum adenocarcinomaRF, random forestROC, receiver operating characteristicSARC, sarcomaSKCM, skin cutaneous melanomaSTAD, stomach adenocarcinomaSVM, support vector machineTCGA, The Cancer Genome AtlasTGCT, testicular germ cell tumorsTHCA, thyroid carcinomaTHYM, thymomaUCEC, uterine corpus endometrial carcinomaUCS, uterine carcinosarcomaUVM, uveal melanomaXGBoost, extreme gradient boosting

Identifiers

PMID32257050
PMCPMC7113609
OpenAlexW3012375969

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.